3-iodobenzylguanidine has been researched along with fluvoxamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baulieu, JL; Besnard, JC; Chalon, S; Chambon, C; Desplanches, G; Guilloteau, D; Huguet, F; Pourcelot, L; Vilar, MP | 1 |
| Buitenhuis, C; Rutgers, M; Smets, LA; Tytgat, GA; Verwijs-Janssen, M; Voûte, PA | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and fluvoxamine
| Article | Year |
|---|---|
Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studies.
Topics: 3-Iodobenzylguanidine; Animals; Blood Platelets; Fluvoxamine; Humans; In Vitro Techniques; Iodine Radioisotopes; Iodobenzenes; Male; Norepinephrine; Oximes; Rats; Rats, Inbred Strains; Serotonin; Tissue Distribution; Tritium | 1988 |
Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Blood Platelets; Fluvoxamine; Humans; In Vitro Techniques; Iodobenzenes; Neuroblastoma; PC12 Cells; Rats; Serotonin; Sympatholytics; Tumor Cells, Cultured; Tyramine | 1993 |